{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:44:46Z","timestamp":1792230286918,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate the association between anterior segment optical coherence tomography (AS-OCT)\u2013derived tube parameters and corneal endothelial cell density (ECD) changes after PreserFlo MicroShunt (PMS) surgery in primary open-angle glaucoma (POAG) and exfoliation glaucoma (XFG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Prospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included pseudophakic patients with POAG or XFG who underwent PMS implantation. ECD was measured preoperatively and at 1, 3, 6, and 12 months post operatively, and every 6 months thereafter. Intracameral tube parameters, including tube position and length, were assessed using AS-OCT images obtained 1 month postoperatively. Associations between OCT parameters and the monthly rate of ECD change (ECD slope) were evaluated using linear mixed-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean preoperative ECD was 2384 \u00b1 391 cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      . Mean follow-up period was 15 \u00b1 7 months, with 5.1 \u00b1 1.3 ECD measurements per eye. Tube parameters did not differ significantly between POAG (67 eyes of 61 patients) and XFG (18 eyes of 16 patients). The mean ECD slope was \u221211.8 \u00b1 2.2 cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      \/month in XFG and \u22129.8 \u00b1 1.1 cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      \/month in POAG (p = 0.38). A greater distance from the angle recess to the intracameral tube entry site was significantly associated with a more negative ECD slope in both XFG and POAG groups (p = 0.02 and 0.03). Its contribution to ECD slope variance was greater in XFG than in POAG (R\n                      <jats:sup>2<\/jats:sup>\n                      = 0.243 vs. 0.069).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A longer distance from the angle recess to the intracameral tube entry site may predict accelerated ECD loss after PMS implantation, particularly in XFG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10384-026-01442-0","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:14:23Z","timestamp":1792228463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between distance from the angle recess to the tube entry site and corneal endothelial cell loss after PreserFlo MicroShunt implantation"],"prefix":"10.1007","author":[{"given":"Shunsuke","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Udagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9566-4587","authenticated-orcid":false,"given":"Tomomi","family":"Higashide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"1442_CR1","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00417-024-06649-w","volume":"263","author":"L Governatori","year":"2025","unstructured":"Governatori L, Oliverio L, Mermoud A, Scampoli A, Sarati F, Carradori A, et al. PreserFlo MicroShunt versus trabeculectomy: an updated meta-analysis and systematic review. Graefes Arch Clin Exp Ophthalmol. 2025;263:885\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1442_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ogla.2025.08.009","volume":"9","author":"JF Panarelli","year":"2026","unstructured":"Panarelli JF, Moster MR, Garcia-Feijoo J, Flowers BE, Baker ND, Barnebey HS, et al. Ab-Externo MicroShunt vs. trabeculectomy in primary open-angle glaucoma: 5-year safety results from a randomized, multicenter study. Ophthalmol Glaucoma. 2026;9:37\u201347.","journal-title":"Ophthalmol Glaucoma."},{"key":"1442_CR3","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/IJG.0000000000002325","volume":"32","author":"F Anton Steindor","year":"2023","unstructured":"Anton Steindor F, Trigaux C, Holtmann C, Spaniol K, Geerling G, Borrelli M. Preserflo MicroShunt: efficacy and endothelial cell density. J Glaucoma. 2023;32:1018\u201321.","journal-title":"J Glaucoma"},{"key":"1442_CR4","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1007\/s00417-024-06508-8","volume":"262","author":"CJ Gassel","year":"2024","unstructured":"Gassel CJ, Wenzel DA, Nasyrov E, Strasser T, Voykov B. Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma\u2014a prospective study over two years. Graefes Arch Clin Exp Ophthalmol. 2024;262:3661\u201370.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1442_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020364","volume":"13","author":"S Dierse","year":"2025","unstructured":"Dierse S, Esser EL, Mert\u00e9 RL, Al-Nawaiseh S, Leclaire MD, Eter N, et al. Preserflo-MicroShunt: postoperative effects on endothelial cell density and corneal thickness. Biomedicines. 2025;13:364.","journal-title":"Biomedicines"},{"key":"1442_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2021.101238","volume":"25","author":"C Chamard","year":"2021","unstructured":"Chamard C, Hammoud S, Bluwol E, Lachkar Y. Endothelial cell loss 5 years after Preserflo MicroShunt implantation: about two cases. Am J Ophthalmol Case Rep. 2021;25:101238.","journal-title":"Am J Ophthalmol Case Rep."},{"key":"1442_CR7","volume":"17","author":"K Iwasaki","year":"2025","unstructured":"Iwasaki K, Takamura Y, Inatani M. Rapid corneal endothelial cell loss after PreserFlo MicroShunt surgery: a case report. Cureus. 2025;17:e83091.","journal-title":"Cureus"},{"key":"1442_CR8","volume":"17","author":"T Watanabe","year":"2025","unstructured":"Watanabe T, Honzawa K, Gunji H, Horiguchi H, Nakano T. A case of corneal endothelial cell loss after PreserFlo MicroShunt implantation requiring device removal and Ahmed Glaucoma Valve implantation with tube insertion into the vitreous cavity. Cureus. 2025;17:e85078.","journal-title":"Cureus"},{"key":"1442_CR9","doi-asserted-by":"publisher","unstructured":"Deie S, Hirose K, Baba T, Okada N, Tokumo K, Fukuto A, et al. Rapid corneal endothelial cell loss following PreserFlo MicroShunt implantation. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.70096.","DOI":"10.1111\/aos.70096"},{"key":"1442_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s40123-021-00428-0","volume":"11","author":"M Ibarz-Barber\u00e1","year":"2022","unstructured":"Ibarz-Barber\u00e1 M, Morales-Fern\u00e1ndez L, Corroto-Cuadrado A, Martinez-Gald\u00f3n F, Ta\u00f1\u00e1-Rivero P, G\u00f3mez deLia\u00f1o R, et al. Corneal endothelial cell loss after PRESERFLO\u2122 Microshunt implantation in the anterior chamber: anterior segment OCT tube location as a risk factor. Ophthalmol Ther. 2022;11:293\u2013310.","journal-title":"Ophthalmol Ther"},{"key":"1442_CR11","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/bjo-2025-328495","volume":"110","author":"T Baba","year":"2026","unstructured":"Baba T, Baba O, Hirose K, Okada N, Tokumo K, Sakaguchi H, et al. Corneal endothelial cell density changes after Preserflo MicroShunt implantation. Br J Ophthalmol. 2026;110:876\u201381.","journal-title":"Br J Ophthalmol"},{"key":"1442_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/IJG.0000000000002719","volume":"35","author":"Y Okada","year":"2026","unstructured":"Okada Y, Mori K, Yoshii K, Inatomi T, Kinoshita S. Twelve-month safety profile of Preserflo\u00ae microshunt on corneal endothelium in glaucoma subtypes. J Glaucoma. 2026;35:393\u2013400.","journal-title":"J Glaucoma"},{"issue":"Suppl 1","key":"1442_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2025-egsguidelines","volume":"109","author":"M Pazos","year":"2025","unstructured":"Pazos M, Traverso CE, Viswanathan A. European Glaucoma Society\u2014terminology and guidelines for glaucoma, 6th edition. Br J Ophthalmol. 2025;109(Suppl 1):1\u2013212.","journal-title":"Br J Ophthalmol"},{"key":"1442_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ophtha.2025.09.012","volume":"133","author":"A Fujita","year":"2026","unstructured":"Fujita A, Elze T, Zhao Y, Lorch AC, Miller JW, Friedman DS, et al. Comparison of glaucoma surgery incidence and outcomes in pseudoexfoliation and primary open-angle glaucoma: IRIS\u00ae registry analysis. Ophthalmology. 2026;133:214\u201322.","journal-title":"Ophthalmology"},{"key":"1442_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/IJG.0000000000001108","volume":"28","author":"T Higashide","year":"2019","unstructured":"Higashide T, Nishino T, Sakaguchi K, Yamada Y, Sugiyama K. Determinants of corneal endothelial cell loss after trabeculectomy with Mitomycin C. J Glaucoma. 2019;28:61\u20137.","journal-title":"J Glaucoma"},{"key":"1442_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201342","volume":"13","author":"K Iwasaki","year":"2018","unstructured":"Iwasaki K, Arimura S, Takihara Y, Takamura Y, Inatani M. Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation. PLoS ONE. 2018;13:e0201342.","journal-title":"PLoS ONE"},{"key":"1442_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/ICO.0b013e3181e16d7d","volume":"30","author":"S Hau","year":"2011","unstructured":"Hau S, Scott A, Bunce C, Barton K. Corneal endothelial morphology in eyes implanted with anterior chamber aqueous shunts. Cornea. 2011;30:50\u20135.","journal-title":"Cornea"},{"key":"1442_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ajo.2024.03.028","volume":"264","author":"G Mahmoudinezhad","year":"2024","unstructured":"Mahmoudinezhad G, Moghimi S, Nishida T, Walker E, Latif K, Liebmann JM, et al. Association of long-term intraocular pressure variability and rate of ganglion complex thinning in patients with glaucoma. Am J Ophthalmol. 2024;264:104\u201319.","journal-title":"Am J Ophthalmol"},{"key":"1442_CR19","doi-asserted-by":"publisher","first-page":"20170213","DOI":"10.1098\/rsif.2017.0213","volume":"14","author":"S Nakagawa","year":"2017","unstructured":"Nakagawa S, Johnson PCD, Schielzeth H. The coefficient of determination R2 and intra-class correlation coefficient from generalized linear mixed-effects models revisited and expanded. J R Soc Interface. 2017;14:20170213.","journal-title":"J R Soc Interface"},{"key":"1442_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1037\/met0000184","volume":"24","author":"JD Rights","year":"2019","unstructured":"Rights JD, Sterba SK. Quantifying explained variance in multilevel models: an integrative framework for defining R2 measures. Psychol Methods. 2019;24:309\u201338.","journal-title":"Psychol Methods"},{"key":"1442_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41433-021-01888-1","volume":"37","author":"Y Aoyama","year":"2023","unstructured":"Aoyama Y, Sakata R, Fujishiro T, Honjo M, Shirato S, Aihara M. Changes in corneal endothelial cell density after initial Ex-PRESS drainage device implantation and its relating factors over 3 years. Eye (Lond). 2023;37:69\u201374.","journal-title":"Eye (Lond)"},{"key":"1442_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/aos.13161","volume":"95","author":"AN Tan","year":"2017","unstructured":"Tan AN, Webers CA, Berendschot TT, de Brabander J, de Witte PM, Nuijts RM, et al. Corneal endothelial cell loss after Baerveldt glaucoma drainage device implantation in the anterior chamber. Acta Ophthalmol. 2017;95:91\u20136.","journal-title":"Acta Ophthalmol"},{"key":"1442_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10384-024-01159-y","volume":"69","author":"H Suzuki","year":"2025","unstructured":"Suzuki H, Sakata R, Yamae T, Ishiyama Y, Sugimoto K, Saito H, et al. Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma. Jpn J Ophthalmol. 2025;69:287\u201395.","journal-title":"Jpn J Ophthalmol"},{"key":"1442_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s10384-025-01265-5","volume":"70","author":"T Yamae","year":"2026","unstructured":"Yamae T, Sakata R, Suzuki H, Aoyama Y, Nemoto H, Saito H, et al. Short-term outcomes of the PreserFlo MicroShunt in Japanese patients with exfoliation glaucoma: a comparison with primary open-angle glaucoma using propensity score matching. Jpn J Ophthalmol. 2026;70:210\u201320.","journal-title":"Jpn J Ophthalmol"},{"key":"1442_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082546","volume":"9","author":"HM Lee","year":"2020","unstructured":"Lee HM, Kim KN, Park KS, Lee NH, Lee SB, Kim CS. Relationship between tube parameters and corneal endothelial cell damage after Ahmed Glaucoma Valve implantation: a comparative study. J Clin Med. 2020;9:2546.","journal-title":"J Clin Med"},{"key":"1442_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/ICO.0000000000000301","volume":"34","author":"EB Koo","year":"2015","unstructured":"Koo EB, Hou J, Han Y, Keenan JD, Stamper RL, Jeng BH. Effect of glaucoma tube shunt parameters on cornea endothelial cells in patients with Ahmed valve implants. Cornea. 2015;34:37\u201341.","journal-title":"Cornea"},{"key":"1442_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ogla.2020.06.012","volume":"4","author":"S Hau","year":"2021","unstructured":"Hau S, Bunce C, Barton K. Corneal endothelial cell loss after Baerveldt Glaucoma implant surgery. Ophthalmol Glaucoma. 2021;4:20\u201331.","journal-title":"Ophthalmol Glaucoma"},{"key":"1442_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.preteyeres.2018.04.002","volume":"66","author":"M Ang","year":"2018","unstructured":"Ang M, Baskaran M, Werkmeister RM, Chua J, Schmidl D, Aranha Dos Santos V, et al. Anterior segment optical coherence tomography. Prog Retin Eye Res. 2018;66:132\u201356.","journal-title":"Prog Retin Eye Res"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01442-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:14:24Z","timestamp":1792228464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01442-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":28,"alternative-id":["1442"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01442-0","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. Nishimura, None; T. Minami, None; S. Udagawa, None; Y. Yamashita, None; T. Suzuki, None; T. Wada, None; T. Higashide, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen).","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}